Related Experiment Videos
Flavonoid glucuronides are substrates for human liver beta-glucuronidase.
K A O'Leary1, A J Day, P W Needs
1Nutrition, Health and Consumer Sciences Division, Institute of Food Research, Norwich, UK.
FEBS Letters
|August 22, 2001
Summary
Human tissues contain beta-glucuronidase enzymes that can break down quercetin glucuronides. This process is crucial for releasing the active quercetin aglycone into cells.
Area of Science:
- Biochemistry
- Human Physiology
- Pharmacology
Background:
- Quercetin glucuronides are the primary circulating metabolites of quercetin in humans.
- Tissue availability of quercetin aglycone may depend on beta-glucuronidase activity against flavonoid glucuronides.
Purpose of the Study:
- To investigate the substrate specificity of beta-glucuronidase towards circulating flavonoid glucuronides.
- To determine the role of human tissues in deconjugating quercetin glucuronides.
Main Methods:
- Assessing beta-glucuronidase activity in human tissues (small intestine, liver, neutrophils) using quercetin glucuronides.
- Testing the inhibitory effect of saccharo-1,4-lactone on beta-glucuronidase activity.
- Evaluating the catalytic efficiency of pure recombinant human beta-glucuronidase on various flavonoid glucuronides.
Main Results:
- Human tissues demonstrated beta-glucuronidase activity against quercetin glucuronides.
- Liver cell-free extracts showed the highest deconjugation efficiency, which was fully inhibited by saccharo-1,4-lactone.
- Recombinant human beta-glucuronidase exhibited varying catalytic efficiencies for different flavonoid glucuronides, with significant differences observed based on substitution positions.
Conclusions:
- Flavonoid glucuronides can be effectively deconjugated by microsomal beta-glucuronidase present in various human cells.
- This deconjugation process is a key step in making quercetin and other flavonoids available within human tissues.